A phase II study of biweekly irinotecan and mitomycin C combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: the Japan Clinical Oncology Group trial (JCOG0109)

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 4071-4071 ◽  
Author(s):  
T. Hamaguchi ◽  
A. Ohtsu ◽  
I. Hyodo ◽  
Y. Arai ◽  
H. Takiuchi ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Combination Therapy ◽  
Advanced Gastric Cancer ◽  
Mitomycin C ◽  
Clinical Oncology ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Oncology Group ◽  
Japan Clinical Oncology Group ◽  
Group Trial

scholarly journals Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: A Japan Clinical Oncology Group trial (JCOG 0805)

2013 ◽  
Vol 104 (9) ◽  
pp. 1211-1216 ◽  
Author(s):  
Chigusa Morizane ◽  
Takuji Okusaka ◽  
Junki Mizusawa ◽  
Atsuo Takashima ◽  
Makoto Ueno ◽  
...  
Keyword(s):  
Clinical Oncology ◽  
Biliary Tract ◽  
Phase Ii ◽  
Biliary Tract Cancer ◽  
Phase Ii Study ◽  
Oncology Group ◽  
Japan Clinical Oncology Group ◽  
Tract Cancer ◽  
Randomized Phase Ii ◽  
Group Trial
Sign in / Sign up

Export Citation Format

Share Document